Table 1.
Comparison of Clinical Baseline Data Among the Diabetes Mellitus, Diabetes Mellitus Combined with PLA and Healthy Control
| Variables | Healthy Control (n = 27) |
Diabetes Mellitus (n = 55) |
Diabetes Mellitus Combined with PLA (n = 22) |
P1 | P2 | P3 |
|---|---|---|---|---|---|---|
| Gender, n (%) | 0.132 | 1 | 0.112 | |||
| Female | 13 (48.148) | 25 (45.455) | 5 (22.727) | |||
| Male | 14 (51.852) | 30 (54.545) | 17 (77.273) | |||
| Age (years), Median (Q1,Q3) | 50 (44.5, 54.5) | 59 (52.5, 70.5) | 59 (52.25, 67.75) | 0.002 | < 0.001 | 0.817 |
| TBIL (μmol/L), Median (Q1,Q3) | 10 (7.8, 11.1) | 9.5 (7.2, 13.9) | 8.6 (6.2, 29.2) | 0.943 | 0.834 | 0.761 |
| ALB (g/L), Median (Q1,Q3) | 44.7 (43.7, 47.8) | 43.1 (40.15, 45.1) | 34.1 (27.5, 37) | < 0.001 | < 0.001 | < 0.001 |
| ALT (U/L), Median (Q1,Q3) | 15 (13, 19) | 22 (14.25, 34) | 35 (26.5, 102.75) | < 0.001 | 0.002 | < 0.001 |
| AST (U/L), Median (Q1,Q3) | 18 (17, 18.5) | 22 (18, 28.75) | 34.5 (26.25, 57.5) | < 0.001 | 0.002 | < 0.001 |
| GGT (U/L), Median (Q1,Q3) | 17 (13, 21) | 23 (14, 40) | 131 (96.5, 191.75) | < 0.001 | 0.009 | < 0.001 |
| ALP (U/L), Median (Q1,Q3) | 68 (55, 76.5) | 69 (55, 82) | 156.5 (119.75, 221.25) | < 0.001 | 0.593 | < 0.001 |
| TCHO (mmol/L), Median (Q1,Q3) | 4.09 (3.835, 4.525) | 4.57 (3.85, 5) | 3.25 (2.985, 3.585) | < 0.001 | 0.054 | < 0.001 |
| Tg (mmol/L), Median (Q1,Q3) | 1.01 (0.785, 1.255) | 1.47 (1.105, 2.23) | 1.16 (0.85, 1.585) | < 0.001 | < 0.001 | 0.034 |
| HDL (mmol/L), Median (Q1,Q3) | 1.319 ± 0.142 | 1.207 ± 0.351 | 0.801 ± 0.293 | < 0.001 | 0.114 | < 0.001 |
| TG/HDL ratio, Median (Q1,Q3) | 0.769 (0.635, 1.02) | 1.219 (0.867, 2.22) | 1.55 (1.018, 2.643) | < 0.001 | < 0.001 | 0.404 |
| LDL (mmol/L), Median (Q1,Q3) | 2.62 (2.42, 2.985) | 2.67 (2.15, 3.24) | 1.92 (1.445, 2.335) | 0.001 | 0.798 | 0.001 |
| APOA1 (g/L), Median (Q1,Q3) | 1.42 (1.355, 1.535) | 1.335 (1.19, 1.53) | 0.68 (0.48, 0.765) | < 0.001 | 0.203 | < 0.001 |
| APOB (g/L), Median (Q1,Q3) | 0.83 (0.76, 0.925) | 0.985 (0.85, 1.192) | 0.85 (0.735, 0.995) | 0.002 | < 0.001 | 0.018 |
| APOC2 (mg/dL), Median (Q1,Q3) | 3.49 (2.967, 3.845) | 4.681 (4.114, 5.712) | 2.470 (2.202, 3.034) | < 0.001 | < 0.001 | < 0.001 |
| GLU (mmol/L), Median (Q1,Q3) | 4.55 (4.34, 4.885) | 7.29 (5.99, 8.59) | 6.535 (5.49, 9.75) | < 0.001 | < 0.001 | 0.594 |
| HBA1c (%), Median (Q1,Q3) | 5.6 (5.175, 6.225) | 7.4 (6.7, 8.8) | 7 (6.15, 8.8) | < 0.001 | < 0.001 | 0.48 |
Notes: P1: One-Way ANOVA of diabetes mellitus, diabetes mellitus with PLA, and healthy control group, P2: Comparison between diabetes mellitus and healthy control, P3: Comparison between diabetes mellitus and diabetes mellitus combined with PLA.